View Archive

Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Commercial Support

This activity is supported by educational grants from AbbVie and Agios Pharmaceuticals, Inc.

Medical Crossfire®: Emerging Applications to Optimize and Individualize AML Treatment

Medical Crossfire®: Emerging Applications to Optimize and Individualize AML Treatment

Friday, June 26, 2020

Live Webcast! 8:00 PM – 10:00 PM ET


Recent advances have led to a marked increase in available treatment options for patients with acute myeloid leukemia (AML). Active investigation into numerous novel agents, combinations of existing therapies, and diagnostic molecular testing continues at a rapid pace. In this dynamic landscape, accurate characterization of disease in newly diagnosed patients is imperative to ensure optimal care and therapeutic targeting.

This live webcast symposium will cover novel strategies and applications, as well as emerging data in AML. The format of the activity will take a historical look at challenges in treatment, highlight emerging new data, and forecast areas of future research and treatment options that address real-world clinical challenges. The innovative, engaging format will include a mix of didactic lecture, Medical Crossfire® discussions among the panel, and case studies that reflect challenges faced in the field, with an opportunity for audience participation.

Benefits of Attending

  • Apply insights from leading experts to clinical cases to optimally use targeted therapy for patients with AML
  • Implement strategies to manage AML with current and emerging agents and best practices in supportive care
  • Recognize practical caveats to planning treatment regimens for difficult cases, such as those of older adults with AML
  • Implement increased knowledge of treatment options for relapsed/refractory AML into daily clinical practice

Acknowledgement of Commercial Support

This activity is supported by educational grants from AbbVie and Agios Pharmaceuticals, Inc.

Target Audience

This educational activity is directed toward medical oncologists, hematologists, and other oncology health care professionals interested in the latest advances in the treatment of patients with AML. Fellows, researchers, nurses, nurse practitioners, physician assistants, and other health care professionals interested in the treatment of patients with AML are also invited to attend.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Utilize clinical, genomic, and molecular criteria to diagnose, characterize mutations, and assess risk in patients with AML
  • Integrate clinical evidence for recently approved therapeutic agents into current treatment paradigms across the continuum of care for patients with AML
  • Optimize and individualize treatment selection for patients with AML in frontline and relapsed/refractory settings, including elderly patients and those unfit for intensive induction regimens
  • Review ongoing investigational studies designed to evaluate novel therapies for AML in the context of unmet clinical needs and clinical trial opportunities for appropriate patients
  • Implement appropriate strategies for recognizing and managing potential treatment-related toxicities in patients undergoing therapy for AML

Program Chair

Gail J. Roboz, MD
Gail J. Roboz, MD
Professor of Medicine
Director, Clinical and Translational Leukemia Programs
Weill Cornell Medicine
The New York-Presbyterian Hospital
New York, NY


2 Ways to Register
  1. Online: click here.
  2. Phone: Please call (888) 949-0045 or (609) 378-3701.
Physicians' Education Resource®
2 Clarke Drive
Suite 110
Cranbury, NJ 08512
Registration Fee - Free

For registration assistance, please email info@gotoper.com, or call (888) 949-0045 or (609) 378-3701.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the ADA and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call (609) 378-3701.

Physicians' Education Resource®, LLC reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited.  This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting Continuing Education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image"). By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as a part of the Affordable Care Act (ACA). Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the ACA.


You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

Professional Information


Calendar of Events
Filter By